Industry: Chemical & Material
Published Date: 2026-04-27
Pages: 142 Pages
Report ld: 6641832
Request Sample
Customized Report
Polycaprolactam Market Size(US$)

CAGR 2026-2032
6.3%
Market Size,2032
USD 12,930
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Polycaprolactam market was valued at US$ 8480 million in 2025 and is anticipated to reach US$ 12930 million by 2032, at a CAGR of 6.3% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Polycaprolactam competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
The North American market for Polycaprolactam is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Polycaprolactam is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Polycaprolactam include BASF SE, Honeywell, Royal DSM N.V, Lanxess, Clariant Corporation, Unitika, DOMO Chemicals, Firestone Textiles Company, Grupa Azoty, LIBOLON, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Polycaprolactam market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Polycaprolactam. The Polycaprolactam market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Polycaprolactam market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Polycaprolactam manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Polycaprolactam manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Polycaprolactam production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Polycaprolactam consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Polycaprolactam Market Overview
1.1 Product Definition
1.2 Polycaprolactam by Type
1.2.1 Global Polycaprolactam Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Standard Type
1.2.3 Reinforced Type
1.3 Polycaprolactam by Application
1.3.1 Global Polycaprolactam Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Automotive
1.3.3 Machinery
1.3.4 Electronic Appliances
1.3.5 Chemical Building Materials
1.4 Global Market Growth Prospects
1.4.1 Global Polycaprolactam Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Polycaprolactam Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Polycaprolactam Production Estimates and Forecasts (2021–2032)
1.4.4 Global Polycaprolactam Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Polycaprolactam Production Market Share by Manufacturers (2021–2026)
2.2 Global Polycaprolactam Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Polycaprolactam, Industry Ranking, 2024 vs 2025
2.4 Global Polycaprolactam Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Polycaprolactam Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Polycaprolactam, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Polycaprolactam, Product Offerings and Applications
2.8 Global Key Manufacturers of Polycaprolactam, Date of Entry into the Industry
2.9 Polycaprolactam Market Competitive Situation and Trends
2.9.1 Polycaprolactam Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Polycaprolactam Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Polycaprolactam Production by Region
3.1 Global Polycaprolactam Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Polycaprolactam Production Value by Region (2021–2032)
3.2.1 Global Polycaprolactam Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Polycaprolactam by Region (2027–2032)
3.3 Global Polycaprolactam Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Polycaprolactam Production Volume by Region (2021–2032)
3.4.1 Global Polycaprolactam Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Polycaprolactam by Region (2027–2032)
3.5 Global Polycaprolactam Market Price Analysis by Region (2021–2032)
3.6 Global Polycaprolactam Production, Value, and Year-over-Year Growth
3.6.1 North America Polycaprolactam Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Polycaprolactam Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Polycaprolactam Production Value Estimates and Forecasts (2021–2032)
3.6.4 Japan Polycaprolactam Production Value Estimates and Forecasts (2021–2032)
4 Polycaprolactam Consumption by Region
4.1 Global Polycaprolactam Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Polycaprolactam Consumption by Region (2021–2032)
4.2.1 Global Polycaprolactam Consumption by Region (2021–2026)
4.2.2 Global Polycaprolactam Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Polycaprolactam Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Polycaprolactam Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Polycaprolactam Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Polycaprolactam Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Polycaprolactam Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Polycaprolactam Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Polycaprolactam Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Polycaprolactam Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Polycaprolactam Production by Type (2021–2032)
5.1.1 Global Polycaprolactam Production by Type (2021–2026)
5.1.2 Global Polycaprolactam Production by Type (2027–2032)
5.1.3 Global Polycaprolactam Production Market Share by Type (2021–2032)
5.2 Global Polycaprolactam Production Value by Type (2021–2032)
5.2.1 Global Polycaprolactam Production Value by Type (2021–2026)
5.2.2 Global Polycaprolactam Production Value by Type (2027–2032)
5.2.3 Global Polycaprolactam Production Value Market Share by Type (2021–2032)
5.3 Global Polycaprolactam Price by Type (2021–2032)
6 Segment by Application
6.1 Global Polycaprolactam Production by Application (2021–2032)
6.1.1 Global Polycaprolactam Production by Application (2021–2026)
6.1.2 Global Polycaprolactam Production by Application (2027–2032)
6.1.3 Global Polycaprolactam Production Market Share by Application (2021–2032)
6.2 Global Polycaprolactam Production Value by Application (2021–2032)
6.2.1 Global Polycaprolactam Production Value by Application (2021–2026)
6.2.2 Global Polycaprolactam Production Value by Application (2027–2032)
6.2.3 Global Polycaprolactam Production Value Market Share by Application (2021–2032)
6.3 Global Polycaprolactam Price by Application (2021–2032)
7 Key Companies Profiled
7.1 BASF SE
7.1.1 BASF SE Polycaprolactam Company Information
7.1.2 BASF SE Polycaprolactam Product Portfolio
7.1.3 BASF SE Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 BASF SE Main Business and Markets Served
7.1.5 BASF SE Recent Developments/Updates
7.2 Honeywell
7.2.1 Honeywell Polycaprolactam Company Information
7.2.2 Honeywell Polycaprolactam Product Portfolio
7.2.3 Honeywell Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Honeywell Main Business and Markets Served
7.2.5 Honeywell Recent Developments/Updates
7.3 Royal DSM N.V
7.3.1 Royal DSM N.V Polycaprolactam Company Information
7.3.2 Royal DSM N.V Polycaprolactam Product Portfolio
7.3.3 Royal DSM N.V Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Royal DSM N.V Main Business and Markets Served
7.3.5 Royal DSM N.V Recent Developments/Updates
7.4 Lanxess
7.4.1 Lanxess Polycaprolactam Company Information
7.4.2 Lanxess Polycaprolactam Product Portfolio
7.4.3 Lanxess Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Lanxess Main Business and Markets Served
7.4.5 Lanxess Recent Developments/Updates
7.5 Clariant Corporation
7.5.1 Clariant Corporation Polycaprolactam Company Information
7.5.2 Clariant Corporation Polycaprolactam Product Portfolio
7.5.3 Clariant Corporation Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Clariant Corporation Main Business and Markets Served
7.5.5 Clariant Corporation Recent Developments/Updates
7.6 Unitika
7.6.1 Unitika Polycaprolactam Company Information
7.6.2 Unitika Polycaprolactam Product Portfolio
7.6.3 Unitika Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Unitika Main Business and Markets Served
7.6.5 Unitika Recent Developments/Updates
7.7 DOMO Chemicals
7.7.1 DOMO Chemicals Polycaprolactam Company Information
7.7.2 DOMO Chemicals Polycaprolactam Product Portfolio
7.7.3 DOMO Chemicals Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 DOMO Chemicals Main Business and Markets Served
7.7.5 DOMO Chemicals Recent Developments/Updates
7.8 Firestone Textiles Company
7.8.1 Firestone Textiles Company Polycaprolactam Company Information
7.8.2 Firestone Textiles Company Polycaprolactam Product Portfolio
7.8.3 Firestone Textiles Company Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Firestone Textiles Company Main Business and Markets Served
7.8.5 Firestone Textiles Company Recent Developments/Updates
7.9 Grupa Azoty
7.9.1 Grupa Azoty Polycaprolactam Company Information
7.9.2 Grupa Azoty Polycaprolactam Product Portfolio
7.9.3 Grupa Azoty Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Grupa Azoty Main Business and Markets Served
7.9.5 Grupa Azoty Recent Developments/Updates
7.10 LIBOLON
7.10.1 LIBOLON Polycaprolactam Company Information
7.10.2 LIBOLON Polycaprolactam Product Portfolio
7.10.3 LIBOLON Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 LIBOLON Main Business and Markets Served
7.10.5 LIBOLON Recent Developments/Updates
7.11 Polymeric Resources Corporation
7.11.1 Polymeric Resources Corporation Polycaprolactam Company Information
7.11.2 Polymeric Resources Corporation Polycaprolactam Product Portfolio
7.11.3 Polymeric Resources Corporation Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 Polymeric Resources Corporation Main Business and Markets Served
7.11.5 Polymeric Resources Corporation Recent Developments/Updates
7.12 UBE
7.12.1 UBE Polycaprolactam Company Information
7.12.2 UBE Polycaprolactam Product Portfolio
7.12.3 UBE Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 UBE Main Business and Markets Served
7.12.5 UBE Recent Developments/Updates
7.13 EMS-Grivory
7.13.1 EMS-Grivory Polycaprolactam Company Information
7.13.2 EMS-Grivory Polycaprolactam Product Portfolio
7.13.3 EMS-Grivory Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 EMS-Grivory Main Business and Markets Served
7.13.5 EMS-Grivory Recent Developments/Updates
7.14 Shakespeare
7.14.1 Shakespeare Polycaprolactam Company Information
7.14.2 Shakespeare Polycaprolactam Product Portfolio
7.14.3 Shakespeare Polycaprolactam Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 Shakespeare Main Business and Markets Served
7.14.5 Shakespeare Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Polycaprolactam Industry Chain Analysis
8.2 Polycaprolactam Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Polycaprolactam Production Modes and Processes
8.4 Polycaprolactam Sales and Marketing
8.4.1 Polycaprolactam Sales Channels
8.4.2 Polycaprolactam Distributors
8.5 Polycaprolactam Customer Analysis
9 Polycaprolactam Market Dynamics
9.1 Polycaprolactam Industry Trends
9.2 Polycaprolactam Market Drivers
9.3 Polycaprolactam Market Challenges
9.4 Polycaprolactam Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 139
USD 3950.00
(Single User License)
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 166
USD 4900.00
(Single User License)
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 91
USD 4250.00
(Single User License)
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 121
USD 3950.00
(Single User License)
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published Date: 2025-02-24
Pages: 105
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-31
Pages: 103
USD 2900.00
(Single User License)
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published Date: 2024-01-16
Pages: 121
USD 3950.00
(Single User License)
The global market for Polycaprolactam was estimated to be worth US$ 8480 million in 2025 and is projected to reach US$ 12930 million, growing at a CAGR of 6.3% from 2026 to 2032.
Published: 2026-07-14
Pages: 139
The global Polycaprolactam market is projected to grow from US$ 8025 million in 2024 to US$ 12230 million by 2031, at a CAGR of 6.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 166
The global Polycaprolactam market size was US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 91
The global market for Polycaprolactam was estimated to be worth US$ 8025 million in 2024 and is forecast to a readjusted size of US$ 12230 million by 2031 with a CAGR of 6.3% during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 121
The global market for Polycaprolactam was valued at US$ 8025 million in the year 2024 and is projected to reach a revised size of US$ 12230 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Published: 2025-02-24
Pages: 105
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-31
Pages: 103
Polycaprolactam (Polyamid 6, PA6, als Handelsmarke Perlon) ist ein Polymer aus der Gruppe der Polyamide. Dieses Polymer wurde erstmals 1938 von Paul Schlack (I.G. Farben) synthetisiert, um die Eigenschaften von Nylon 6,6 zu reproduzieren, ohne das geltende Produktionspatent zu verletzen.
Published: 2024-01-16
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now